Follow
Ravi Raghani
Ravi Raghani
Unknown affiliation
Verified email at umich.edu
Title
Cited by
Cited by
Year
Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer
Y Zhang, KR Hughes, RM Raghani, J Ma, S Orbach, JS Jeruss, LD Shea
Biomaterials 269, 120666, 2021
222021
A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs
J Wang, R Ocadiz-Ruiz, MS Hall, GG Bushnell, SM Orbach, JT Decker, ...
Nature Communications 14 (1), 4790, 2023
62023
Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
RM Raghani, JA Ma, Y Zhang, SM Orbach, J Wang, M Zeinali, S Nagrath, ...
Frontiers in Oncology 12, 1039993, 2022
12022
Abstract LB347: A lung-mimicking synthetic metastatic niche reveals N1 neutrophils drive breast cancer metastatic dormancy in the lungs
J Wang, R Ocadiz-Ruiz, M Hall, G Bushnell, S Orbach, J Decker, ...
Cancer Research 83 (8_Supplement), LB347-LB347, 2023
2023
Drug-free biodegradable nanoparticles alleviate myeloid cell-induced immunosuppression and inhibit metastasis.
J Ma, R Raghani, Y Zhang, S Orbach, T Murthy, J Podojil, A Elhofy, ...
Journal of Clinical Oncology 40 (16_suppl), e14555-e14555, 2022
2022
Immunotherapeutic and Diagnostic Potential of Engineered Materials
R Raghani
2022
Abstract LB-360: Foreign body responses create a highly active anti-tumor environment to recruit and eradicate metastatic cells
J Wang, M Hall, G Bushnell, J Decker, S Orbach, R Raghani, Y Zhang, ...
Cancer Research 80 (16_Supplement), LB-360-LB-360, 2020
2020
Cargo-free scaffold implant recruits metastatic cancer cells via lung-mimicking myeloid cell S100A8/A9 axis
J Wang, MS Hall, GG Bushnell, SM Orbach, RM Raghani, Y Zhang, ...
bioRxiv, 789974, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8